GSK shares dive as sales weaken and costs rise nervous investors

Summary

British pharma company reports falling profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live latest updates Shares in GSK slid on Wednesday despite the UK drugmaker...